TIPE3 and breast carcinoma: In addition, we also found that the expression level of TIPE3 is higher in HER2-positive breast cancer cells (SKBR3) than that in HER2-negative breast cancer cells (MCF-7 and MDA-MB-231) (Supplementary Figure 1A) [27–29].